A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
Summary
- Conditions
- Chronic Hepatitis B
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04846491
- Collaborators
- Peking University First Hospital
- Investigators
- Principal Investigator: Guiqiang Wang, Ph.D Peking University First Hospital